Related references
Note: Only part of the references are listed.Eradication of Hepatitis C Virus (HCV) Reduces Immune Activation, Microbial Translocation, and the HIV DNA Level in HIV/HCV-Coinfected Patients
Luis F. Lopez-Cortes et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated Cirrhosis
Sabela Lens et al.
GASTROENTEROLOGY (2017)
Eradication of Hepatitis C Virus and Non-Liver-Related Non-Acquired Immune Deficiency Syndrome-Related Events in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection
Juan Berenguer et al.
HEPATOLOGY (2017)
Association of Hepatitis C Virus Infection With CD4/CD8 Ratio in HIV-Positive Women
Mark H. Kuniholm et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2016)
CD4 and CD4/CD8 ratio progression in HIV-HCV infected patients after achievement of SVR
A. Saracino et al.
JOURNAL OF CLINICAL VIROLOGY (2016)
During Hepatitis C Virus (HCV) Infection and HCV-HIV Coinfection, an Elevated Plasma Level of Autotaxin Is Associated With Lysophosphatidic Acid and Markers of Immune Activation That Normalize During Interferon-Free HCV Therapy
Lenche Kostadinova et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Gut epithelial barrier dysfunction in human immunodeficiency virus-hepatitis C virus coinfected patients: Influence on innate and acquired immunity
Mercedes Marquez et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Impact of hepatitis C virus coinfection on T-cell dynamics in long-term HIV-suppressors under combined antiretroviral therapy
Olivia Zaegel-Faucher et al.
AIDS (2015)
Coinfection by Hepatitis C Is Strongly Associated with Abnormal CD4/CD8 Ratio in HIV Patients under Stable ART in Salvador, Brazil
Clara Brites-Alves et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2015)
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study
Cristina Mussini et al.
LANCET HIV (2015)
Immune Activation Response in Chronic HIV-Infected Patients: Influence of Hepatitis C Virus Coinfection
Mercedes Marquez et al.
PLOS ONE (2015)
Gut Epithelial Barrier Dysfunction and Innate Immune Activation Predict Mortality in Treated HIV Infection
Peter W. Hunt et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Increased Risk of Serious Non-AIDS-Related Events in HIV-Infected Subjects on Antiretroviral Therapy Associated with a Low CD4/CD8 Ratio
Sergio Serrano-Villar et al.
PLOS ONE (2014)
HIV-Infected Individuals with Low CD4/CD8 Ratio despite Effective Antiretroviral Therapy Exhibit Altered T Cell Subsets, Heightened CD8+T Cell Activation, and Increased Risk of Non-AIDS Morbidity and Mortality
Sergio Serrano-Villar et al.
PLOS PATHOGENS (2014)
Benefits From Sustained Virologic Response to Pegylated Interferon Plus Ribavirin in HIV/Hepatitis C Virus-Coinfected Patients With Compensated Cirrhosis
Jose A. Mira et al.
CLINICAL INFECTIOUS DISEASES (2013)
The CD4/CD8 ratio in HIV-infected subjects is independently associated with T-cell activation despite long-term viral suppression
Sergio Serrano-Villar et al.
JOURNAL OF INFECTION (2013)
Long-Term Suppressive Combined Antiretroviral Treatment Does Not Normalize the Serum Level of Soluble CD14
Gema Mendez-Lagares et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Effect of hepatitis C virus on immunological and virological responses in HIV-infected patients initiating highly active antiretroviral therapy: a meta-analysis
C. G. Tsiara et al.
JOURNAL OF VIRAL HEPATITIS (2013)
Factors Associated With Discordance Between Absolute CD4 Cell Count and CD4 Cell Percentage in Patients Coinfected With HIV and Hepatitis C Virus
Mark W. Hull et al.
CLINICAL INFECTIOUS DISEASES (2012)
Sustained Virological Response to Interferon Plus Ribavirin Reduces Non-Liver-Related Mortality in Patients Coinfected With HIV and Hepatitis C Virus
Juan Berenguer et al.
CLINICAL INFECTIOUS DISEASES (2012)
Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count
Giulia Marchetti et al.
AIDS (2011)
Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection
Netanya G. Sandler et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Impact of hepatitis C viral replication on CD4+ T-lymphocyte progression in HIV-HCV coinfection before and after antiretroviral therapy
Martin Potter et al.
AIDS (2010)
The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection
Salvador Vergara et al.
CLINICAL INFECTIOUS DISEASES (2007)
Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study
A. Mocroft et al.
LANCET (2007)
The impact of cirrhosis on CD4+ T cell counts in HIV-seronegative patients
Barbara H. McGovern et al.
CLINICAL INFECTIOUS DISEASES (2007)
CD4 percentage is an independent predictor of survival in patients starting antiretroviral therapy with absolute CD4 cell counts between 200 and 350 cells/μL
D. M. Moore et al.
HIV MEDICINE (2006)
CD4 lymphocyte percentage predicts disease progression in HIV-infected patients initiating highly active antiretroviral therapy with CD4 lymphocyte counts >350 lymphocytes/mm3
T Hulgan et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Impact of hepatitis C virus on immune restoration in HIV-infected patients who start highly active antiretroviral therapy: A meta-analysis
MF Miller et al.
CLINICAL INFECTIOUS DISEASES (2005)
Share Paper
